Insider · CIK 0002077227
Sai Rangarao
Files at PTHS (Pelthos Therapeutics Inc.). First filing -, latest -.
Sai Rangarao files SEC Form 4 as officer at PTHS (Pelthos Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sai Rangarao has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | PTHS Pelthos Therapeutics Inc. | AGrant or award Restricted Stock Unitsderivative | +30,518 | - | - | 30,518 | Jul 21, 2025 |
| Jul 2, 2025 | PTHS Pelthos Therapeutics Inc. | AGrant or award Stock Optionderivative | +93,000 | - | - | 93,000 | Jul 21, 2025 |
Questions about Sai Rangarao
Answered from the filings on this page, as of the latest one.
Is Sai Rangarao buying or selling?
Sai Rangarao has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sai Rangarao's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sai Rangarao has 0.
Where does Sai Rangarao file Form 4?
Sai Rangarao has filed Form 4 at PTHS (Pelthos Therapeutics Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.